These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17541384)

  • 1. Serum uric acid, the endothelium and hypertension: an association revisited.
    Reynolds T
    J Hum Hypertens; 2007 Aug; 21(8):591-3. PubMed ID: 17541384
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension.
    Feig DI; Rodriguez-Iturbe B; Nakagawa T; Johnson RJ
    Hypertension; 2006 Jul; 48(1):25-6. PubMed ID: 16682608
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between serum uric acid and prehypertension among US adults.
    Syamala S; Li J; Shankar A
    J Hypertens; 2007 Aug; 25(8):1583-9. PubMed ID: 17620953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?
    Perez-Ruiz F; Lioté F
    Arthritis Rheum; 2007 Oct; 57(7):1324-8. PubMed ID: 17907217
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ; Prior C; Puig JG
    Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered uric acid levels and disease states.
    Kutzing MK; Firestein BL
    J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension.
    Feig DI; Nakagawa T; Karumanchi SA; Oliver WJ; Kang DH; Finch J; Johnson RJ
    Kidney Int; 2004 Jul; 66(1):281-7. PubMed ID: 15200435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid and the developmental origins of hypertension.
    Bonamy AK
    Am J Hypertens; 2009 Apr; 22(4):349. PubMed ID: 19308028
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of red wine on antioxidant status in vivo.
    Maxwell S; Thorpe G
    Eur Heart J; 2000 Sep; 21(17):1482-3. PubMed ID: 10952841
    [No Abstract]   [Full Text] [Related]  

  • 10. Uric acid and cardiovascular risk.
    Hebert LA; Rovin B
    N Engl J Med; 2009 Jan; 360(5):540; author reply 540-1. PubMed ID: 19186313
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperuricosuria, an often overlooked cause of recurrent oliguria in children.
    Akl K
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):619-23. PubMed ID: 18580023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid: bystander or culprit in hypertension and progressive renal disease?
    Menè P; Punzo G
    J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.
    Rodilla E; Pérez-Lahiguera F; Costa JA; González C; Miralles A; Moral D; Pascual JM
    Med Clin (Barc); 2009 Jan; 132(1):1-6. PubMed ID: 19174057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid: an old dog with new tricks?
    Sanders PW
    J Am Soc Nephrol; 2006 Jul; 17(7):1767-8. PubMed ID: 16775027
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial.
    Baker JF; Schumacher HR; Krishnan E
    Angiology; 2007; 58(4):450-7. PubMed ID: 17875958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum urea and uric acid concentration in pregnant women in sub-urban commercial community in Africa.
    Ahaneku JE; Adinma JI; Ahaneku GI; Nwosu BO; Nwofor PC; Okoli CC
    Niger J Clin Pract; 2009 Jun; 12(2):216-8. PubMed ID: 19764679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazide diuretics exacerbate fructose-induced metabolic syndrome.
    Reungjui S; Roncal CA; Mu W; Srinivas TR; Sirivongs D; Johnson RJ; Nakagawa T
    J Am Soc Nephrol; 2007 Oct; 18(10):2724-31. PubMed ID: 17855639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.